Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

scientific article published on 16 August 2013

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JRR/RRT098
P932PMC publication ID3885131
P698PubMed publication ID23955053
P5875ResearchGate publication ID255975403

P2093author name stringMasanori Fukushima
Minoru Suzuki
Akira Maruhashi
Koji Ono
Yoshinori Sakurai
Yoshihiro Kimura
Kenichi Yoshimura
Shin-Ichiro Masunaga
Yuko Kinashi
Yasunori Ariyoshi
Teruhito Aihara
Shin-Ichi Haginomori
Junichi Hiratsuka
Miyuki Niimi
Ituro Kato
P2860cites workFull-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patientsQ33504332
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.Q34163118
The radiation biology of boron neutron capture therapyQ34491960
First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET.Q40322496
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable diseaseQ41327924
IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.Q44100708
Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancerQ44267907
Effectiveness of BNCT for recurrent head and neck malignanciesQ45016236
Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trialQ46427505
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinomaQ46742361
The Radiation Biology of Boron Neutron Capture TherapyQ54019294
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiationQ68085124
Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective studyQ74105486
Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumorsQ76338473
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancerQ79757577
Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckQ80975892
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studiesQ81416970
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911Q81464422
Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancerQ83132147
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)146-153
P577publication date2013-08-16
P1433published inJournal of Radiation ResearchQ2330802
P1476titleBoron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
P478volume55

Reverse relations

cites work (P2860)
Q640855684-Borono-2-F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research
Q38825221Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET.
Q37630245Boron Neutron Capture Therapy - A Literature Review
Q37348292Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study
Q36184779Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy
Q49255187Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection.
Q38793345Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers
Q39003781Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
Q33881254Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
Q52729361Non-invasive estimation of 10 B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18 F-fluoro-phenylalanine.
Q58611070Proposal for determining absolute biological effectiveness of boron neutron capture therapy-the effect of 10B(n,α)7Li dose can be predicted from the nucleocytoplasmic ratio or the cell size
Q47184614Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy
Q35760848The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
Q42210286The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams
Q64113782Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic Procedures
Q33875030Validation and Comparison of the Therapeutic Efficacy of Boron Neutron Capture Therapy Mediated By Boron-Rich Liposomes in Multiple Murine Tumor Models.
Q48408462Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy